Hillsdale Investment Management Inc. Ptc Therapeutics, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 170 shares of PTCT stock, worth $8,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170
Previous 170
-0.0%
Holding current value
$8,263
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PTCT
# of Institutions
222Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$444 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$384 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$378 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$359 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$352 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.48B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...